Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb) Conference Paper uri icon

authors

  • Meniawy, T
  • Richardson, G
  • Townsend, A
  • Desai, J
  • Gan, H
  • Friedlander, M
  • Horvath, L
  • Jameson, MB
  • Sandhu, S
  • Wu, Z
  • Qin, Z
  • Kang, K
  • Markman, B

publication date

  • September 1, 2017